Are Stronger Label Warnings for Byetta Necessary?

6 more reports of pancreatitis and 2 recent patient deaths have reopened talks between the FDA and Amylin to add stronger warning lables to the diabetes weight-loss drug Byetta. For the full story, read the Reuter's news article.

The FDA first warned of a possible linke between Byetta and acute pancreatitis in October of 2007. For our expert analysis of the story, read Dr. Bill Quick's post here.

David Mendosa has covered Byetta extensively in past posts. For his opinion on the latest Byetta news read his recent comment to the post "Living Longer with Byetta." (View comments and see his reply to #3)

For more information on Byetta click here.